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See Article, pages 257–264We receive with great enthusiasm the recently published article
by Morando and his colleagues from the University of Padova
regarding their experience with a newmodel of care coordination
in the setting of cirrhosis [1]. The burden of chronic disease is
greater now than ever. In the absence of a coordinated effort to
prevent, diagnose, and better manage chronic disease, we as a
society will bear increasing socioeconomic costs over time.
Almost one half of all Americans suffer from one or more
chronic diseases [2]. Millions are diagnosed and millions more
die annually from a chronic disease. This is a reﬂection of the
changing demographics in the developed world, where mortality
from communicable infectious diseases decreases and mortality
from non-communicable chronic diseases continues to increase.
Enormous scientiﬁc advancements in treatment have largely
failed to curb this steady rise. Although current health care
ﬁnancing and delivery systems focus on the treatment of acute
conditions, 78% of actual healthcare spending is spent on the
treatment of chronic conditions [3]. The total burden of chronic
diseases on the economy exceeds $1.3 trillion annually; of this
amount, $277 billion is spent annually on treatment, with lost
productivity totaling $1.1 trillion. At our current pace, by 2023
we can expect a 42% increase in the incidence of chronic disease,
totaling $4.2 trillion annually in treatment costs and lost eco-
nomic output [4].
Chronic liver disease and cirrhosis are leading causes of death
in the United States and worldwide. In the United States, an esti-
mated 30,000 new cases of cirrhosis are diagnosed each year, and
cirrhosis overall accounts for over 150,000 annual hospitaliza-
tions [5]. Treatment costs associated with the sequelae of cirrho-
sis such as variceal bleeding, ascites, encephalopathy, and
hepatocellular carcinoma exceed $4 billion annually, exclusive
of estimates of lost economic output [6]. In stark contrast to most
other malignancies, hepatocellular carcinoma is increasing in
frequency, with associated expenditures doubling from 1988 toJournal of Hepatology 20
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with metabolic syndrome and obesity, emerging chronic diseases
such as fatty liver disease and non-alcoholic steatohepatitis are
predicted to become the most common cause of cirrhosis, and
will overtake hepatitis C as the most common indication for liver
transplantation in the United States by 2030 [8].
Frequent hospital readmissions for management of ﬂuid over-
load, hepatic encephalopathy, and/or gastrointestinal hemor-
rhage are commonplace among patients with cirrhosis. A recent
study from Volk and colleagues from the University of Michigan
found that 69% of patients with cirrhosis had at least one non-
elective readmission, with a median time to ﬁrst readmission of
67 days [9]. In a sobering statistic, 14% of patients were readmit-
ted within one week, and 37% within one month. One patient was
readmitted 40 times. 22% of readmissions were found to be pos-
sibly preventable. The study concluded that readmission among
patients with cirrhosis was common, costly, moderately predict-
able, possibly preventable, and independently associated with
mortality [9].
In recent years, care coordination, or ‘‘collaborative care’’, has
emerged as a highly effective concept that can help reduce read-
mission rates in patients who are known to be at high risk for
readmission. The concept of care coordination has been applied
in disorders such as depression, coronary artery disease, conges-
tive heart failure, and poorly-controlled diabetes, with studies
generally demonstrating improved control of the underlying dis-
eases [10]. In theory, care coordination by speciﬁcally trained
personnel should result in fewer readmissions, improved out-
comes, and reduced expenditures. However, studies have also
suggested that viable programs without a strong transitional
care component are unlikely to yield signiﬁcant savings [11].
Current care of patients with cirrhosis is fragmented and
poorly coordinated. While many ‘‘evidence-supported’’ practice
guidelines have been published in recent years regarding the
common complications of cirrhosis, current literature suggests
that patients with cirrhosis often fail to receive these evidence
and guideline-supported treatments [6,12]. Furthermore, the
hospitalist movement has separated the outpatient physician
from the inpatient physician, creating discontinuity at a critical
juncture in patient care. A study of physician continuity of care13 vol. 59 j 203–204 Open access under CC BY-NC-ND license.
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between 1996 and 2006 showed that while continuity of care
decreased overall, one-third of this decrease was attributed to
the increasing involvement of hospitalists [13]. This and many
other reasons have made the process of coordinating care peril-
ous and challenging [14].
It is in this context that the study byMorando and colleagues is
highly signiﬁcant [1]. This study represents the ﬁrst prospective
trial in the cirrhosis population comparing the traditional system
involving the family physician and punctual consultation to a spe-
cialist, with a new coordinated care system involving close mon-
itoring by a specialized team of nurses, physicians-in-training,
and hepatologists. The results clearly favor the care coordination
model, both in costs and survival. The study demonstrated
reduced 30-day readmission (42% vs. 15%), reduced 12-month
readmission (71% vs. 46%), reduced 12-month mortality (46% vs.
23%), and a 46% cost reduction overall. An important point to
emphasize is that patients with cirrhosis and ascites who are
discharged from the hospital following treatment of an acute
decompensation represent a unique population for which
follow-up and specialist management is highly relevant, as they
are predisposed to developing potentially preventablemajor com-
plications resulting in readmission or mortality. Expertise is
needed for early detection and treatment of these complications.
The integration of care coordination at this critical juncture likely
explains the impressive results of the study; in other diseases the
number of cases required to ﬁnd signiﬁcant differences is often
much higher.
The study is obviously not without its limitations. Under-
standably, the study was not randomized as it would be difﬁcult
to recruit patients for a randomized study in which they would
receive either ‘‘standard care’’ vs. orchestrated care from a multi-
disciplinary team of specialists and nurses. Further, it was not
clear whether the specialists involved in the care coordination
group provided a standardized level of care or whether certain
specialists had disproportionately better outcomes. It has been
shown in a previous study of patients with cirrhosis and ascites
in the Veterans Affairs Health System that health care quality
was higher in patients who received specialist care from a gastro-
enterologist [12]. In our opinion, a liver-focused gastroenterolo-
gist would probably provide higher quality specialty care as
compared to a general gastroenterologist. Finally, the study does
not include various non-hospital expenses such as nursing home
stays and home caregiving, although the overall savings in reduc-
ing emergent hospital readmissions should still make this model
economically feasible.
Because the management of cirrhosis and other chronic dis-
eases are multidisciplinary in nature and quickly becoming a high
policy priority in the era of healthcare reform, improving care
coordination should improve the quality and efﬁciency of care
and provide business opportunities for gastroenterologists [6].
At our current institution, we are investigating efforts to integrate
a similar model of care coordination in an attempt to reduce
readmissions, reduce expenditures, and improve survival. Our
coordinator would help coordinate inpatient-to-clinic transitions,
call patients on a routine basis to prevent non-elective visits to
the Emergency Department, place ‘‘smart-scales’’ in patient
homes to monitor body weight remotely, and facilitate interac-
tion with other healthcare professionals. They would also help
facilitate transfers to hospice or skilled nursing facilities, espe-
cially for patients who are either unsuitable for transplantation
due to medical comorbidities or who are unable to undergo204 Journal of Hepatology 201transplantation due to technical reasons or due to organ shortage.
Patients in this latter category are left in a challenging situation
as they may be ‘‘too well for transplant’’, yet are extremely sick
with a decreased quality of life and decreased life expectancy
due to the development of other cirrhosis-related complications.
Too many die awaiting liver transplantation [15]. In this setting,
care coordination would serve an instrumental role in providing
the best possible quality of life in the face of a terminal diagnosis,
with seamless timely transitions from ‘‘listed for transplant’’ to
palliative care [16].
As our healthcare expenditures continue to grow and the bur-
den of chronic disease continues to increase, care coordination is
an obvious solution and a ‘‘win-win’’ situation for patients, care-
givers, providers, and healthcare expenditures alike.Conﬂict of interest
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